DE602006020576D1 - Verfahren zur gliomdiagnose mit unterscheidung zwischen progressiven und de-novo-formen - Google Patents

Verfahren zur gliomdiagnose mit unterscheidung zwischen progressiven und de-novo-formen

Info

Publication number
DE602006020576D1
DE602006020576D1 DE602006020576T DE602006020576T DE602006020576D1 DE 602006020576 D1 DE602006020576 D1 DE 602006020576D1 DE 602006020576 T DE602006020576 T DE 602006020576T DE 602006020576 T DE602006020576 T DE 602006020576T DE 602006020576 D1 DE602006020576 D1 DE 602006020576D1
Authority
DE
Germany
Prior art keywords
gliom
progressives
novo
diagnosis
distinguished
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
DE602006020576T
Other languages
English (en)
Inventor
Somasundaram Kumaravel
Alangar Sathyaranjan Hegde
Sridevi Hegde
Paturu Kondaiah
Manchanahalli Rangsaswamy Rao
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Council of Scientific and Industrial Research CSIR
Original Assignee
Council of Scientific and Industrial Research CSIR
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Council of Scientific and Industrial Research CSIR filed Critical Council of Scientific and Industrial Research CSIR
Publication of DE602006020576D1 publication Critical patent/DE602006020576D1/de
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
    • C12Q1/6886—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material for cancer
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/112—Disease subtyping, staging or classification

Landscapes

  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Zoology (AREA)
  • Immunology (AREA)
  • Wood Science & Technology (AREA)
  • Pathology (AREA)
  • Genetics & Genomics (AREA)
  • Analytical Chemistry (AREA)
  • Microbiology (AREA)
  • General Engineering & Computer Science (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Physics & Mathematics (AREA)
  • Oncology (AREA)
  • Hospice & Palliative Care (AREA)
  • Biochemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biotechnology (AREA)
  • General Health & Medical Sciences (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Other Investigation Or Analysis Of Materials By Electrical Means (AREA)
  • Inspection Of Paper Currency And Valuable Securities (AREA)
  • Measuring And Recording Apparatus For Diagnosis (AREA)
  • Investigating Or Analyzing Materials By The Use Of Ultrasonic Waves (AREA)
  • Diaphragms For Electromechanical Transducers (AREA)
DE602006020576T 2005-07-26 2006-07-20 Verfahren zur gliomdiagnose mit unterscheidung zwischen progressiven und de-novo-formen Active DE602006020576D1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
IN1975DE2005 2005-07-26
PCT/IB2006/001986 WO2007012937A2 (en) 2005-07-26 2006-07-20 Method for diagnosis of glioma distinguishing between progressive and denovo types

Publications (1)

Publication Number Publication Date
DE602006020576D1 true DE602006020576D1 (de) 2011-04-21

Family

ID=37683709

Family Applications (1)

Application Number Title Priority Date Filing Date
DE602006020576T Active DE602006020576D1 (de) 2005-07-26 2006-07-20 Verfahren zur gliomdiagnose mit unterscheidung zwischen progressiven und de-novo-formen

Country Status (7)

Country Link
US (1) US7754426B2 (de)
EP (1) EP1907579B1 (de)
JP (1) JP5025648B2 (de)
AT (1) ATE501276T1 (de)
DE (1) DE602006020576D1 (de)
DK (1) DK1907579T3 (de)
WO (1) WO2007012937A2 (de)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP5738599B2 (ja) * 2008-01-07 2015-06-24 カウンスィル オブ サイエンティフィック アンド インダストリアル リサーチＣｏｕｎｃｉｌ Ｏｆ Ｓｃｉｅｎｔｉｆｉｃ ＆ Ｉｎｄｕｓｔｒｉａｌ Ｒｅｓｅａｒｃｈ 星状細胞腫の同定と分級を行う方法、星状細胞腫の同定と分級を行う際に使用するキット
US8688224B2 (en) * 2008-03-07 2014-04-01 Tremont Electric, Inc. Implantable biomedical device including an electrical energy generator
WO2011040575A1 (ja) 2009-09-30 2011-04-07 株式会社日本触媒 ポリアクリル酸（塩）系吸水性樹脂およびその製造方法
US9335332B2 (en) 2010-04-01 2016-05-10 Council Of Scientific And Industrial Research Nicotinamide phosphoribosyltransferase (NMPRTase) inhibitor for glioma therapy
US11821043B2 (en) 2017-08-17 2023-11-21 Nantomics Llc Dynamic changes in circulating free RNA of neural tumors

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2002061144A2 (en) * 2001-01-31 2002-08-08 Whitehead Institute For Biomedical Research Brain tumor diagnosis and outcome prediction
WO2004112829A2 (en) * 2003-05-23 2004-12-29 Genentech, Inc. Compositions and methods for the diagnosis and treatment of tumors of glial origin

Also Published As

Publication number Publication date
ATE501276T1 (de) 2011-03-15
EP1907579A2 (de) 2008-04-09
JP2009512420A (ja) 2009-03-26
DK1907579T3 (da) 2011-06-27
US7754426B2 (en) 2010-07-13
WO2007012937B1 (en) 2007-07-26
JP5025648B2 (ja) 2012-09-12
WO2007012937A3 (en) 2007-05-18
WO2007012937A2 (en) 2007-02-01
EP1907579B1 (de) 2011-03-09
US20070072216A1 (en) 2007-03-29

Similar Documents

Publication Publication Date Title
CY1120961T1 (el) Δοσολογικες μορφες απο του στοματος που περιλαμβανουν αντιαιμοπεταλιακο παραγοντα και αναστολεα οξεος
EA200801046A1 (ru) Неинвазивный способ выявления переходно-клеточной карциномы мочевого пузыря in vitro
CY1120741T1 (el) Θεραπεια οζωδους σκληρυνσης
CY1118452T1 (el) Ενωσεις και συνθεσεις ως αναστολεις πρωτεϊνικης κινασης
TW200622950A (en) Methods of monitoring the concentration of an analyte
NO345046B1 (no) Oral doseringsform
MX2009012625A (es) Metodos para el tratamiento, diagnostico y deteccion de trastornos asociados con el fgf21.
MX2008006076A (es) Metodos, composiciones y kits para el tratamiento de condiciones medicas.
DE602005014127D1 (de) Medizinische vorrichtung und herstellungsverfahren dafür
EA200870185A1 (ru) Комбинации ингибиторов ang2 и vegf
UA96139C2 (uk) Антитіло до нейропіліну-1 (nrp1)
ATE549416T1 (de) Verfahren und zusammensetzungen zum nachweis von autoimmunkrankheiten
MX2009013649A (es) Variantes geneticas en el cromosoma 15q24 como marcadores para usarse en diagnostico, prognosis y tratamiento de sindrome de exfoliacion y glaucoma.
EP1788093A4 (de) Gerät, verfahren und kit zum nachweis von bakterien
UY29995A1 (es) Uso de un antagonista de cb1 para tratar efectos secundarios y síntomas negativos de la esquizofrenia
DE602005002311D1 (de) Vorrichtung zur Wiederherstellung des Sehens
NO20055563L (no) Midler for behandlingen av lavere abdominale lidelser
DE602006020576D1 (de) Verfahren zur gliomdiagnose mit unterscheidung zwischen progressiven und de-novo-formen
CY1116083T1 (el) Μεθοδος για τον εντοπισμο τυπων του ιου των ανθρωπινων θηλωματων (hpv)
ITPI20060094A1 (it) Apparecchiatura per la valutazione dell'acuita' visiva di un individuo.
NO20072285L (no) S-mirtazapin for behandling av hetetokter
DE602004021740D1 (de) Reliningsverfahren für dentalen Prothesen
NO20064896L (no) Fremgangsmater for behandling av autoimmune og inflammatoriske sykdommer
WO2008034071A3 (en) Method of identifying patients suitable for high-dose cyclophosphamide treatment
WO2007105223A3 (en) Methods of diagnosing pon1-hdl associated lipid disorders

Legal Events

Date Code Title Description
R082 Change of representative

Ref document number: 1907579

Country of ref document: EP

Representative=s name: BOEHMERT & BOEHMERT, DE